○Md. Golzar Hossain1, Keiji Ueda2
(1. Department of Microbiology and Hygiene, Bangladesh Agricultural University (Bangladesh), 2. Division of Virology, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Japan (Japan))
○sharmeen fayyaz1, rishikesh lotke3, isabell Haussmann2, Moritz Peterson2, Daniel Sauter2
(1. National Institute of Virology (Pakistan), 2. 1.Institute for Medical Virology and Epidemiology of Viral Diseases (Germany), 3. 3.Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig (Germany))
○Hina Miyazaki1, Shungo Adachi2, Kosuke Takada1, Shintaro Shichinohe1, Itsuki Anzai1, Tokiko Watanabe1,3,4
(1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. National Cancer Center Research Institute (Japan), 3. Center for Infectious Disease Education and Research (CiDER), The University of Osaka (Japan), 4. Center for Advanced Modalities and DDS (CAMaD), The University of Osaka (Japan))
○Maryam Sani Lawal1,2,3, Kyoko Hayashida1,2, Tatsuki Sugi 1,2, Patrick Reteng 4, Junya Yamagishi1,2,5
(1. Graduate School of Infectious Diseases, Hokkaido University, Sapporo, Japan. (Japan), 2. Division of Collaboration and Education International Institute for Zoonosis Control (Japan), 3. National Reference Laboratory, Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria (Nigeria), 4. Department of Infection and Immunity, Luxembourg Institute of Health Luxembourg City, Luxembourg (Japan), 5. Global Station for Zoonosis Control, GI-CoRE, Hokkaido University, Sapporo, Hokkaido, Japan (Japan))
○Makoto Shimooka1, Tomomi Kirino1, Harumi Yamaguma2, Natsumi Kameoka2, Hina Miyazaki1, Itsuki Anzai1, Shintaro Shichinohe1, Satoshi Obika3,4,5,6, Yuuya Kasahara2,5, Tokiko Watanabe1,3,4
(1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. National Institutes of Biomedical Innovation, Health and Nutrition (Japan), 3. Center for Infectious Disease Education and Research, The University of Osaka (Japan), 4. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 5. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 6. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan))
○Qingxin Li1, Shintaro Shichinohe1, Hiroki Tanaka2,3, Jessica Anindita3, Sara Yoshimoto1, Kaewaroon Nantaporn1,4, Makoto Shimooka1, Itsuki Anzai1, Hidetaka Akita2,3, Tokiko Watanabe1,2,5
(1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 3. Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University (Japan), 4. The National Vaccine Institute (Thailand), 5. Center for Infectious Disease Education and Research (CiDER), The University of Osaka (Japan))
○Merveille Kapandji1, Htin Lin2, Maurine Mumo Mutua1, Qiang xu1,3, Ryosaku Oshiro1, Catarina Harumi Oda1, Khine Mya Nwe1, Shyam Prakash Dumre4, Kyaw Zin Thant5, War War Aung2, Aye Aye Khin2, Hlaing Myat Thu2, Takeshi Urano6, Kouichi Morita1,3,6,7, Yuki Takamatsu1, Mya Myat Ngwe Tun1,3,6,7
(1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Medical Research, Ministry of Health (Myanmar), 3. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan), 4. Central Department of Microbiology, Tribhuvan University (Nepal), 5. Myanmar Academy of Medical Science (Myanmar), 6. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 7. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan))
○MAN LIU1, Da Teng1, Tomoyuki Honda1
(1. Okayama University (Japan))
○Thi Thanh Ngan Nguyen1,3, Mya Myat Ngwe Tun1,2,5,6, Thi Bich Hau Vu3, Thi Thu Thuy Nguyen3, Vu Mai Phuong Hoang3, Le Khanh Hang Nguyen3, Muhareva Raekiansyah1, Jean Claude Balingit1, Corazon C. Buerano1, Yuki Takamatsu2, Thi Quynh Mai Le3, Futoshi Hasebe4, Kouichi Morita1,2,5,6
(1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Japan), 3. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. (Viet Nam), 4. Vietnam Research Station, Center for Infectious Disease Researcher in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Viet Nam), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan (Japan), 6. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo, Japan (Japan))
○Micheal Teron Pillay1,2, Mai Thi Quynh Le3, Yuki Takamatsu1, Phong Vu Tran3, Noboru Minakawa1
(1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Vaccine Informatics (Japan), 3. National Institute of Hygiene and Epidemiology (Viet Nam))
○Po-hung Wang1, Kazuo Yamashita1
(1. KOTAI Biotechnologies, Inc. (Japan))
○Kazuma Okada1,2, Junki Hirano1,2,3, Kentaro Uemura1,2,3, Chikako Ono1,2,3, Shuhei Taguwa1,2,3, Yoshiharu Matsuura1,2,3
(1. Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University (Japan), 2. Research Institute for Microbial Diseases (RIMD), Osaka University (Japan), 3. Center for Advanced Modalities and DDS (CAMaD), Osaka University (Japan))
○Hisano Yajima1, Yuki Anraku2, Yu Kaku3, Tomo Nomai2, Kanako Terakado Kimura1, Yoshiko Nakada-Nakura1, Arnon Plianchaisuk3, Kaho Okumura3,5, Yusuke Atarashi1, Takuya Hemmi1, Daisuke Kuroda6, Yoshimasa Takahashi4, Shunsuke Kita2, Jiei Sasaki1, Hiromi Sumita1, Jumpei Ito3, Katsumi Maenaka2, Kei Sato3, Takao Hashiguchi1
(1. Kyoto University (Japan), 2. Hokkaido University (Japan), 3. The University of Tokyo (Japan), 4. Japan Institute for Health Security (Japan), 5. Sophia University (Japan), 6. Nihon University (Japan))
○Koji Yamauchi1,2, Yukiko Muramoto1,2, Yoko Fujita-Fujiharu1,2,3, Ai Hirabayashi1, Chiharu Nogami1,3, Tsubasa Ishida1,2, Yukihiko Sugita1,2, Shinji Saito4,5, Kaori Sano4,6, Tadaki Suzuki4,7, Masahiro Nakano1,2,4, Takeshi Noda1,2,8
(1. Laboratory of Ultrastructural Virology, Institue for Life and Medical Sciences, Kyoto University (Japan), 2. Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University (Japan), 3. Department of Cell and Virus Structure, Max Plank Institute of Biochemistry (Germany), 4. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 5. Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan), 6. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 7. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan), 8. Institute for Integrated Cell-Material Sciences, Kyoto University (Japan))
○TRINH THI NGUYEN1
(1. Seoul National University College of Medecine (Korea))
○Hiharu Inoue1, Takayuki Wada1,2
(1. Grad. Sch. Hum Life Ecol., Osaka Metro. Univ. (Japan), 2. Osaka Intl. Res. Ctr. Infect. Dis., Osaka Metro. Univ. (Japan))
○Stephen Anyona OMAE1,2,5, Shah Mohammad1, Hien Anh Thi Nguyen3, Kim Mai Huynh4, Natsuki Ariyoshi1, Tien Vu Phan4, Liên Thuy Le4, Hoang Huy Le3, Luong Dinh Nguyen1,2,4, Hirono Otomaru1, Erik Koehne1, Minh Xuan Bui6, Michiko Toizumi1, Hung Do Thai1,4, Lay Myint Yoshida1,2
(1. Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University (Japan), 3. National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam (Viet Nam), 4. Pasteur Institute in Nha Trang, Vietnam (Viet Nam), 5. Kenya Medical Research Institute, Nairobi, Kenya (Kenya), 6. Khanh Hoa Department of Health, Vietnam (Viet Nam))
○Jun A Komano1, Shinya Yonogi2, Mayuko Yagi1, Tomohiro Hasei1, Masahiko Hayashi3, Yuh Shiwa4, Fumito Maruyama5, Daisuke Tanaka6, Tomoaki Okuda7, Teruya Maki8
(1. Osaka Med Pharm Univ (Japan), 2. Osaka Institute of Public Health (Japan), 3. Fukuoka University (Japan), 4. Tokyo University of Agriculture (Japan), 5. Hiroshima University (Japan), 6. University of Toyama (Japan), 7. Keio University (Japan), 8. Kindai University (Japan))
○Fang-Ching Shen1, Yun-Ju Lee1, Chia-Yu Chi1
(1. National Health Research Institutes (Taiwan))
○BoNian Chen1, Wei-Yang Sit1, Wen-Ching Wang1
(1. NTHU (Taiwan))
○Augustin Tshibaka Kabongo1,2,6, Rajib Acharjee1,2, Takaya Sakura1,2, Ozan Gundogdu3, Jun-ichi Kishikawa4, Tomoo Shiba4, Kiyoshi Kita1, Daniel Ken Inaoka1,2,5
(1. School of Tropical Medicine and Global Health, Nagasaki University (Japan), 2. Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 3. London School of Hygiene & Tropical Medicine (LSHTM), London (UK), 4. Department of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology (Japan), 5. Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo (Japan), 6. Faculty of Medicine, Public Health and and Pharmacy, University of Mbujimayi (Democratic Republic of the Congo))
○Dr Mohammad Sohail1,2, Abhishek Mitra1, Dr Ajay Kumar Sharma1, Dr Birendra Kumar Gupta1
(1. Vinoba Bhave University (India), 2. Centre for Tribal Health and Biotechnology Foundation (India))
○Huai Chuang1,2, Yuka Appelboom1,2,3, Yuko Katakai4, Satoru Kawai5,6, Miako Sakaguchi7, Osamu Kaneko1,2
(1. Dept. Protozoology, Institute of Tropical Medicine, Nagasaki Univ. (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki Univ. (Japan), 3. Master’s program of Biomedical Sciences, Leiden Univ. Medical Center, Leiden Univ. (Netherlands), 4. The Corporation for Production and Research of Laboratory Primates (Japan), 5. Dept. Tropical Medicine and Parasitology, Dokkyo Medical Univ. (Japan), 6. Amami Laboratory of Injurious Animals Institute of Medical Science, The Univ. Tokyo (Japan), 7. Central Laboratory, Institute of Tropical Medicine, Nagasaki Univ. (Japan))
○Ayana Maeda1, Takaaki Yuguchi1, Hikaru Nagaoka1, Takafumi Tsuboi1, Eizo Takashima1
(1. Division of Malaria Research, Proteo-Science Center , Ehime University (Japan))
○Thant Zin Tun1, Nattawat Chaiyawong1, Takahiro Ishizaki1, Masahito Asada1, Kazuhide Yahata1, Minami Baba1, Osamu Kaneko1
(1. Institute of Tropical Medicine, Nagasaki University (Japan))
○Parool Gupta1,2, Priya Priydarshni1, Vahab Ali1
(1. Department of Biochemistry, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna-800020, Bihar (INDIA) (India), 2. Department of Pharmacy, Buddha Institute of Pharmacy, Gorakhpur-273209, Uttar Pradesh (INDIA) (India))
○Xiaotong Zhu1, Gang He1, Yonghui Feng1, Dawei He1, Yaming Cao1, Osamu Kaneko2
(1. China Medical University (China), 2. Nagasaki University (Japan))
○Li Zheng1, Yu Song1, Osamu Kaneko2, Yaming Cao1
(1. China Medical University (China), 2. Institute of Tropical Medicine Nagasaki University (Japan))
○Hikaru Nagaoka1, Dorcas Gyamah Bredu2, Linda Eva Amoah2, Eizo Takashima1
(1. Malaria Research, Proteo Science Center, Ehime University, Japan (Japan), 2. Noguchi Memorial Institute for Medical Research, University of Ghana (Ghana))
○Sara Ahmed Habash Mohamed1,7, Naofumi Takahashi1, Youssef M. El Talkhawy1, Randa A. Abdelnaser1, Hiromi Ogata Aoki2,8, Seiji Okada2, Hitoshi Takizawa3, Shingo Usuki4, Kan Etoh5, Shinjiro Hino5, Saori Morino Koga6, Minetaro Ogawa6, Shinya Suzu1
(1. Division of Infection & Hematopoiesis,Joint Research Center for Human Retrovirus Infection,Kumamoto University (Japan), 2. Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University (Japan), 3. Laboratory of Stem Cell Stress, International Research Center for Medical Sciences (IRCMS), Kumamoto University (Japan), 4. Liaison Laboratory Research Promotion Center,Institute of Molecular Embryology and Genetics, Kumamoto University (Japan), 5. Department of Medical Cell Biology,Institute of Molecular Embryology and Genetics, Kumamoto University (Japan), 6. Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University (Japan), 7. Department of Clinical Pathology,Faculty of Medicine ,Suez Canal University,Ismailia (Egypt), 8. Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo (Japan))
○ziyan Wan1,2, Nuo Liu1,2, Ting Hua1,2, Huimin Chen1,2, Xiaolong Li1,2,3
(1. University of Science and Technology of China (China), 2. State Key Laboratory of Immune Response and Immunology (China), 3. First Affiliated Hospital of USTC (China))
Janyerkye Tulyeu1, Jonas Søndergaard1, David Priest1, Takeshi Ebihara4, Hisatake Matsumoto4, Mara Llamas-Covarrubias1, Masaki Imai5, Shinichi Esaki4, Shinichi Iwasaki5, Akimichi Morita4, Sayuri Yamazaki5, Shimon Sakaguchi2, ○James Badger Wing1,2,3
(1. CiDER, The University of Osaka (Japan), 2. IFReC, The University of Osaka (Japan), 3. CAMaD, The University of Osaka (Japan), 4. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine (Japan), 5. Nagoya City University Graduate School of Medical Sciences (Japan))
○Ting Hua1,2,3, Nuo Liu1,2,3, Ziyan Wan1,2,3, Yingying Tao1,2,3, Xiaolong Li1,2,3
(1. University of Science and Technology of China (China), 2. The First Affiliated Hospital of USTC (China), 3. State Key Laboratory of Immune Response and Immunology (China))
○Syed M. Faisal1,2,3, Andrea Comba1,2,3, Maria L Varela1,2,3, Maria G Castro1,2,3, Pedro R Lowenstein1,2,3
(1. Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America), 2. Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America), 3. Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America))
○hendra saputra ismanto1, Daron M Standley1
(1. research institute for microbial diseases, the university of osaka (Japan))
○Benedicta Obenewaa Dankyi1, Takaaki Yuguchi1, Rattanaporn Rojrung1, Hikaru Nagaoka1, Bernard N. Kanoi2, Alfred B. Tiono3, Issa Nebie3, Alphonse Ouedraogo3, Kazutoyo Miura4, Jetsumon Sattabongkot5, Sodiomon B. Sirima3, Takafumi Tsuboi6, Eizo Takashima1
(1. Ehime University (Japan), 2. Mount Kenya University (Kenya), 3. Groupe de Recherche Action en Sante (GRAS) (Burkina Faso), 4. National Institutes of Health (United States of America), 5. Mahidol University (Thailand), 6. Proteo-Science Center, Ehime University (Japan))
○Sachidananda Behera1,2,3, Mehar Darukhshan Kalim1, Krishna Pandey4, Shubhankar Kumar Singh2, Vahab Ali1
(1. Department of Biochemistry, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna-800007, Bihar, INDIA (India), 2. Department of Immunology and Microbiology, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna-800007, Bihar, INDIA (India), 3. Department of Clinical Research, S. S. Hospital and Research Institute, Kankarbagh, Patna-800020, Bihar, INDIA (India), 4. Department of Clinical Medicine, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna-800007, Bihar, INDIA (India))
○Jalal Alshaweesh1, Rashmi Dash1, Areej Sakkour2, Mariana Silva Almieda1, Chizu Sanjoba 4, Yasuyuki GOTO4, Koji Kobiyama2, Hamano Shinjiro3, Ken J Ishii2, Cevayir Coban1
(1. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo (Japan), 2. Division of Vaccine Science, Department of Microbiology and Immunology, IMSUT, The University of Tokyo, Japan. (Japan), 3. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki, Japan. (Japan), 4. Laboratory of Molecular Immunology, Department of Animal Resource Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Japan))
○Shara Bakytbek1,2,3, Farzaneh Valanezhad1,2,3, Ayako Hyuga1,2,3, Shin-Ichi Inoue2,4, Yui Katsuyuki5, Shusaku Mizukami3,6, Risa Nakamura1,2,3, Haruka Abe11, Futoshi Hasebe2,11, Kazuhide Onoguchi7, Sebastian Kapell8,9, Kouichi Morita3,10, Shinjiro Hamano1,2,3
(1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 5. SHIONOGI Global Infectious Diseases Division Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 6. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 8. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 9. NEC OncoImmunity AS, Ullernchausseen 64/66, 0379, Oslo (Norway), 10. Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 11. Vietnam Research Station, center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan))
○Farzaneh Valanezhad1, Jalal Alshaweesh2, Shara Bakytbek1, Sakiko Shimizu3, Ryo Tanaka3, Yoichiro Iwase3, Risa Nakamura1, Greg Matlashewski4, Sreenivas Gannavaram5, Hira Nakhasi5, Abhay Satoskar6, Shinjiro Hamano1
(1. 1-Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki, Japan (Japan), 2. 4-The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Japan (Japan), 3. 5-TERUMO Corporation, Medical Care Solutions Company, Pharmaceutical Solutions Division, R&D, Japan (Japan), 4. 6-Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada (Canada), 5. 7-Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 US (United States of America), 6. 8-Department of Pathology, The Ohio State University, Columbus, Ohio, US (United States of America))
○Jordan Villa1, Taishi Onodera2, Saya Moriyama2, Ayumi Kitano2, Yoshimasa Takahashi2, Kazuo Yamashita1
(1. KOTAI Biotechnologies, Inc (Japan), 2. Research Center for Vaccine Development, National Institute of Infectious Diseases (NIID) (Japan))
○Sebastian Kapell1,2, Shara Bakytbek4,6, Jean Claude Balingit6, Farzaneh Valanezhad4,6, Ayako Hyuga4,6, Shin-Ichi Inoue8, Yui Katsuyuki8, Shusaku Mizukami5,6, Shinjiro Hamano4,6, Matheus Ferraz2, Ioannis Vardaxis2, Daiki Miura3, Daiki Mori3, Kazuhide Onoguchi3, Kaidre Bendjama1,2, Basu Dev Pandey10, Corazon Cerilla Buerano7, Trevor Clancy, Satoshi Kaneko6,9, Kouichi Morita6,7
(1. Dept. of Vacc. Inform., Inst. of Trop. Med., Nagasaki Univ. (Japan), 2. NEC Oncoimmunity AS (Norway), 3. NEC Corporation (Japan), 4. Dept. Parasitol., Inst. Trop. Med., Nagasaki Univ. (Japan), 5. Dept. of Immun. Regul., Inst. of Trop. Med., Nagasaki Univ. (Japan), 6. Vaccine Research and Development Center Infectious Disease Research Alliance (DEJIMA), Nagasaki Univ. (Japan), 7. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine Nagasaki Uni. (Japan), 8. Dept. of Immunol., Grad. Sch. of Biomed. Sci., Nagasaki Univ. (Japan), 9. Dept. of Eco-epidemiol., Inst. of Trop. Med., Nagasaki Univ. (Japan), 10. Dept. of Mol. Epi., Inst. of Trop., Med., Nagasaki Univ. (Japan))
